Skip to content
CancerIndex

Loading the knowledge graph…

GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors — knowledge graph · CancerIndex